Re: Farmas USA
HZNP.
4. Horizon Pharma, Inc. (HZNP, Earnings, Analysts, Financials): Develops and commercializes medicines for the treatment of arthritis, pain, and inflammatory diseases. Market cap at $148.41M, most recent closing price at $2.41. Net institutional purchases in the current quarter at 22.6M shares, which represents about 54.03% of the company’s float of 41.83M shares. Over the last six months, insiders were net buyers of 575,356 shares, which represents about 1.38% of the company’s 41.83M share float.
Re: Farmas USA
Re: Farmas USA
Re: Farmas USA
Teoría Raclitiana:
1. intentar pillarla abajo
2. vender cuando suba un poco cara a la Fda, y soltarlas
3. Esperara esas bajadas de escándalos que molan verlas desde la barrera, no metidas ahí
4. Comprar y ya decidir si soltar enseguida o bien jugarte las cartas si están claras a la decisión final..
si parece hasta fácil y todo!!jaja ;-)